Key Takeaways Retatrutide is an investigational weight-loss drug showing strong results in trials, but it is not FDA-approved yet
1c and Extended Data Fig
These injectable therapies are sensitive to temperature and light, and even minor mistakes in handling can reduce their effectiveness
That said, when we attempt to pharmacologically interfere with, preserve, or augment the bodys innate physiological processes, there are bound to be side effects and adverse events
What the research shows Hair shedding on GLP1 medications is primarily a condition called telogen effluvium, a temporary increase in hair loss triggered by physical stress on the body
When a person stops taking the medication, its effects halt, too, and a person may return to their previous calorie consumption